Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 701–800 of 1,001
Advances in Arbovirus Surveillance, Detection and Diagnosis
Hall, R. A., Blitvich, B. J., Johansen, C. A., & Blacksell, S. D. (2012) · BioMed Research International · doi:10.1155/2012/512969 · Cited by 40
Chatterjee, S., Kordbacheh, R., & Sin, J. (2024) · Microorganisms · doi:10.3390/microorganisms12020274 · Cited by 26
Finkel, A. M., Trump, B. D., Bowman, D., & Maynard, A. (2018) · Environment Systems & Decisions · doi:10.1007/s10669-018-9688-3 · Cited by 27
“The dengue virus contributes to approximately 50 million infections, 500,000 hospitalizations, and 25,000 deaths annually (Guzman et al. 2010; Bhatt et al. 2013).”
BackgroundSantiago, G. A., González, G. L., Cruz-López, F., & Muñoz‐Jordán, J. L. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01957-18 · Cited by 26
“quently placing approximately 40% of the world population at risk (1, 6).”
BackgroundCoagulation abnormalities in dengue and dengue haemorrhagic fever patients
Hassan, J., Borhany, M., Abid, M., Zaidi, U., Fatima, N., & Shamsi, T. S. (2019) · Transfusion Medicine · doi:10.1111/tme.12658 · Cited by 26
“5 billion people are at risk of infection worldwide, out of which approximately 975 million live in regions of South East Asia, America and the Pacific.(1) Suspected dengue outbreaks were recorded in Pakistan, Saudi Arabia, Yemen, Sudan and Madagascar in 2005 to 2006.”
BackgroundInfluentialChang, C. Y., Rajappan, M., Zaid, M., & Ong, E. L. C. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3422 · Cited by 26
Development of clinical decision rules to predict recurrent shock in dengue
Huy, N. T., Thảo, N. T., Hà, T. T., Lan, N. T. P., Nga, P. T. T., Thúy, T. T., Tuấn, H. M., Nga, C. T. P., Tuong, V. V., Dat, T. V., et al. (2013) · Critical Care · doi:10.1186/cc13135 · Cited by 27
“It is quickly spreading to South America and Africa [1].”
BackgroundCommunity perspectives on dengue transmission in the city of Dhaka, Bangladesh.
Dhar-Chowdhury, P., Haque, C., Driedger, S., & Hossain, S. (2014) · International Health · doi:10.1093/inthealth/ihu032 · Cited by 24
Opsoclonus-myoclonus-ataxia syndrome associated with dengue virus infection
Tan, A. H., Linn, K., Ramli, N. M., Hlaing, C. S., Aye, A. M. M., Sam, I., Ng, C. G., Goh, K. J., Tan, C. T., & Lim, S. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.09.002 · Cited by 26
Glycosphingolipid GM3 is Indispensable for Dengue Virus Genome Replication
Wang, K., Wang, J., Ta, S., Bian, G., Pan, W., Feng, T., Wang, P., Li, Y., & Dai, J. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15641 · Cited by 28
“DENV is widely distributed in subtropical and tropical areas of the world and infect 50–100 million individuals every year[1, 2].”
Aguiar, M., & Stollenwerk, N. (2017) · Communication in Biomathematical Sciences · doi:10.5614/cbms.2017.1.1.1 · Cited by 26
“Sequential infection increases the risk of developing severe dengue, due to a process described as antibody-dependent enhancement (ADE), where the pre-existing antibodies to previous dengue infection enhances the new infection [2], [3], [4].”
BackgroundDhenni, R., Karyanti, M. R., Putri, N. D., Yohan, B., Yudhaputri, F. A., Ma’roef, C. N., Fadhilah, A., Perkasa, A., Restuadi, R., Trimarsanto, H., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006198 · Cited by 26
Anti-TNF-α restricts dengue virus-induced neuropathy
Jhan, M.-K., HuangFu, W., Chen, Y., Kao, J.-C., Tsai, T.-T., Ho, M.-R., Shen, T., Tseng, P., Wang, Y.-T., & Lin, C. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.ma1217-484r · Cited by 26
Tun, M. M. N., Muthugala, R., Nabeshima, T., Soe, A. M., Dumre, S. P., Rajamanthri, L., Jayawardana, D., Attanayake, S., Inoue, S., & Morita, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234508 · Cited by 26
Shen, T., Hanh, V. T., Nguyen, T. Q., Jhan, M.-K., Ho, M.-R., & Lin, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.606743 · Cited by 25
Laboratory-acquired dengue virus infection by needlestick injury: a case report, South Korea, 2014
Lee, C., Jang, E. J., Kwon, D., Choi, H., Park, J. W., & Bae, G. (2016) · Annals of Occupational and Environmental Medicine · doi:10.1186/s40557-016-0104-5 · Cited by 26
“Specifically, when a person who was infected with dengue virus type 1 (DENV-1) is infected secondarily with DENV-2 or dengue virus type 3 (DENV-3), or when a person who was infected with DENV-3 is infected secondarily with DENV-2, it has been reported that the risk of severe dengue fever increases [24, 33].”
BackgroundKestelyn, E., Phuong, C. L., Nuil, J. I. V., Thi, H. T. D., Nguyen, N. M., The, T. D., Chambers, M., Simmons, C. P., Trong, T. N., The, D. N., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15337.1 · Cited by 25
Self-citationTrends and insights in dengue virus research globally: a bibliometric analysis (1995–2023)
Liu, Y., Wang, M., Yu, N., Zhao, W., Wang, P., Zhang, H., Sun, W., Jin, N., & Lu, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05561-5 · Cited by 25
“The Dengue virus (DENV) is a global public health threat transmitted primarily by mosquitoes [1].”
BackgroundKeppeke, G. D., Satoh, M., Ferraz, M. L. G., Chan, E. K. L., & Andrade, L. E. C. (2014) · Immunologic Research · doi:10.1007/s12026-014-8515-2 · Cited by 25
“In contrast, specific anti-Dengue IgG peaks at 15–20 days of infection, but low levels will be maintained throughout the host’s lifetime [40, 41].”
BackgroundAmorim, J. H., Alves, R. P. D. S., Bizerra, R. S. P., Pereira, S. A., Pereira, L. R., Maeda, D. L. N. F., Andreata‐Santos, R., Romano, C. M., & Ferreira, L. C. D. S. (2015) · Virology · doi:10.1016/j.virol.2015.10.006 · Cited by 25
Smith, T. M., Lim, S. P., Yue, K., Busby, S. A., Arora, R., Seh, C. C., Wright, S. K., Nutiu, R., Niyomrattanakit, P., Wan, K. F., et al. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114551141 · Cited by 27
“6 billion people living in tropical and subtropical areas are at risk of dengue infection.(1,2) Annually, there are about 390 million cases, of which 96 million infections exhibit disease symptoms.”
BackgroundAbdullahi, I. N., Agbede, O. O., Dangana, A., Baba, M., & Haruna, A. S. (2016) · Virus Research · doi:10.1016/j.virusres.2016.12.011 · Cited by 25
Suganthan, N., Sakthilingham, G., & Kumanan, T. (2020) · SAGE Open Medical Case Reports · doi:10.1177/2050313x20913428 · Cited by 34
Santos, M. C. D., Monteiro, J. D., de Araújo, J. M. G., & Lima, K. M. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-70811-7 · Cited by 25
Chakraborty, S., Alam, S., Sayem, M., Sanyal, M., Das, T., Saha, P., Sayem, M., Byapari, B. K., Tabassum, C. T., Kabir, A., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100624 · Cited by 25
Prevalence of arbovirus antibodies in young healthy adult population in Brazil
Salgado, B. B., Maués, F. C. D. J., Pereira, R. L., Chiang, J. O., Freitas, M. N. O., Ferreira, M. S., Martins, L. C., Vasconcelos, P. F. D. C., Ganoza, C. A., & Lalwani, P. J. (2021) · Parasites & Vectors · doi:10.1186/s13071-021-04901-4 · Cited by 25
Role of non-coding RNAs in Dengue virus-host interaction
Madhry, D., Pandey, K. K., Kaur, J., Rawat, Y., Sapra, L., Ravi Kumar, Y. S., Srivastava, R. K., Bhattacharyya, S., & Verma, B. (2021) · Frontiers in Bioscience-Scholar · doi:10.52586/s552 · Cited by 25
“This upsurge has been mainly attributed due to an increase in population, global warming, immigration-emigration, urbanization, inefficient mosquito control and lack of health care facilities [5–7].”
BackgroundDiscovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases
Kühl, N., Lang, J., Leuthold, M. M., & Klein, C. D. P. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114585 · Cited by 25
“DENV infections often cause flu-like symptoms but can develop into aggravated disease with lethal outcomes [6,7].”
BackgroundSteindorf, V., Srivastav, A. K., Stollenwerk, N., Kooi, B. W., & Aguiar, M. (2022) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2022.112709 · Cited by 25
From dengue outbreaks to endemicity: Reunion Island, France, 2018 to 2021
Vincent, M., Paty, M.-C., Gérardin, P., Balleydier, E., Etienne, A., Daoudi, J., Thouillot, F., Jaffar‐Bandjee, M., de la Réunion, O. B. O. T. S. C. R. D. M. S., & Menudier, L. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.29.2200769 · Cited by 25
“After the infection, immunity is life-long against the same serotype but short-lived against others and the risk of developing a severe form increases in secondary infections and with a longer interval between infections [4,5].”
BackgroundAloia, A. L., Abraham, A. M., Bonder, C. S., Pitson, S. M., & Carr, J. M. (2015) · Mediators of Inflammation · doi:10.1155/2015/509306 · Cited by 29
“…2015 Academic Editor: Caio T. Fagundes Copyright © 2015 Amanda L. Aloia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
MethodCore protein-mediated 5′–3′ annealing of the West Nile virus genomic RNA in vitro
Iványi-Nagy, R., & Darlix, J. (2012) · Virus Research · doi:10.1016/j.virusres.2012.05.003 · Cited by 25
“Infection by arthropod-borne flaviviruses is associated with significant morbidity and mortality worldwide (Gould and Solomon, 2008; Griffin, 2011; Guzman et al., 2010) .”
Figueiredo, L. B., Sakamoto, T., Coelho, L. F. L., Rocha, E. S. D. O., Cota, M. M. G., Ferreira, G. P., de Oliveira, J. G., & Kroon, E. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104516 · Cited by 25
“DENV infection is endemic in more than 100 countries, with tens of millions of cases of dengue fever (DF) recorded per year, including up to 500,000 cases of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), which require hospitalization for supportive treatment [1–2].”
BackgroundChong, L. C., & Khan, A. M. (2019) · BMC Genomics · doi:10.1186/s12864-019-6311-z · Cited by 26
“The arthropod-borne viral infection mostly occurs in tropical and sub-tropical regions, with rural communities increasingly being affected [2, 5].”
BackgroundThe Restrictome of Flaviviruses
Berthoux, L. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00208-3 · Cited by 29
Suwanbamrung, C., Promsupa, S., Doungsin, T., & Tongjan, S. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.04.006 · Cited by 32
Li, X., Cao, H., Wang, Q., Di, B., Wang, M., Lu, J., Pan, L., Yang, L., Mei, M., Pan, X., et al. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.05.002 · Cited by 26
Serotype-Specific Host Responses in Rhesus Macaques after Primary Dengue Challenge
Hickey, A. C., Koster, J. A., Thalmann, C. M., Hardcastle, K., Tio, P., Cardosa, M. J., & Bossart, K. N. (2013) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0145 · Cited by 24
“in DENV-endemic or DENV-epidemic regions, and more than 100 million DENV infections occur each year, ranking it among the most medically significant arthropod-borne diseases.(2,3) Dengue virus is divided into four distinct serotypes (DENV-1, DENV-2, DENV-3, and DENV-4) and each has a worldwide distribution coexistent…”
BackgroundVerma, M., Bhatnagar, S., Kumari, K., Mittal, N., Sukhralia, S., Shruthi Gopirajan, A. T., Dhanaraj, P. S., & Lal, R. (2019) · Gene · doi:10.1016/j.gene.2019.02.001 · Cited by 24
“The positive stranded RNA genome of dengue virus is of 10.7 Kb size and composed of three structural proteins (Envelope, Capsid, Membrane) and seven nonstructural proteins (NS1, NS2A, NS2B,NS3, NS4A, NS4B, NS5) (Imrie et al., 2010; Guzman et al., 2010; Sukhralia et al., 2018) .”
BackgroundInfluentialSwain, S., Bhatt, M., Pati, S., & Magalhães, R. J. S. (2019) · Infectious Diseases of Poverty · doi:10.1186/s40249-019-0541-9 · Cited by 24
Single molecule, near full-length genome sequencing of dengue virus
Adikari, T. N., Riaz, N., Sigera, C., Leung, P., Valencia, B. M., Barton, K., Smith, M. A., Bull, R. A., Li, H., Luciani, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75374-1 · Cited by 24
Dengue virus infection induces inflammation and oxidative stress on the heart
Kangussu, L. M., Costa, V. V., Olivon, V. C., Queiroz‐Junior, C. M., Gondim, A. N. S., Melo, M. B., Costa, D. E. F. D. R., Nóbrega, N. R. C., de Araújo, N. F., Rachid, M. A., et al. (2021) · Heart · doi:10.1136/heartjnl-2020-318912 · Cited by 24
Modeling Dengue Immune Responses Mediated by Antibodies: A Qualitative Study
Sebayang, A. A., Fahlena, H., Anam, V., Knopoff, D. A., Stollenwerk, N., Aguiar, M., & Soewono, E. (2021) · Biology · doi:10.3390/biology10090941 · Cited by 24
“This disease augmentation phenomenon is called antibody-dependent enhancement (ADE) [3,6,7,18,19] and its occurrence in dengue has been used to explain the etiology of severe disease [7,20–22], which has been shown to be correlated with higher viral loads [23–26].”
BackgroundInfluentialCastillo-Morales, R. M., Serrano, S. O., Villamizar, A. L. R., Méndez‐Sánchez, S. C., & Duque, J. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-03819-2 · Cited by 30
Köpke, C., Rothe, C., Zeder, A., Boecken, G., Feldt, T., Janke, C., Jordan, S., Köhler, C., Löbermann, M., Müller, A., et al. (2025) · Journal of Travel Medicine · doi:10.1093/jtm/taaf004 · Cited by 24
Chowdhury, P. D., Haque, C. E., & Driedger, S. M. (2015) · Risk Analysis · doi:10.1111/risa.12501 · Cited by 28
“5 billion people are at risk to dengue infection.(5,6) In Bangladesh, a tropical country in South Asia, periodic outbreaks of dengue have been recorded since 1964,(7) with the first epidemic in”
BackgroundA Hospital Based Serosurveillance Study of Dengue Infection in Jaipur (Rajasthan) , India
Sood, S. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/5562.3357 · Cited by 24
Clustering, climate and dengue transmission
Junxiong, P., & Yee-Sin, L. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1028364 · Cited by 24
“Current perspective on dengue transmission Dengue incidence is increasing worldwide and is expanding to new geographical regions during recent decades [2,87,88].”
BackgroundMining local climate data to assess spatiotemporal dengue fever epidemic patterns in French Guiana
Flamand, C., Fabrègue, M., Bringay, S., Ardillon, V., Quénel, P., Desenclos, J. C., & Teisseire, M. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002348 · Cited by 24
Epidemiology and characteristics of the dengue outbreak in Guangdong, Southern China, in 2014
Huang, L., Luo, X., Shao, J., Yan, H., Qiu, Y., Ke, P., Zheng, W., Xu, B., Li, W., Sun, D., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2540-5 · Cited by 24
“An estimated 50–400 million dengue infections occur worldwide annually [1, 2].”
BackgroundSilva, A. D. D., Fernando, A., Malavige, G. N., Perera, K. L. N., Premawansa, S., & Ogg, G. S. (2015) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.170501 · Cited by 24
“However, a conclusive understanding of the mechanisms underlying why only some patients develop the more severe forms of the infection is lacking.[4]”
BackgroundAnti‐flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside Analogues
McGuigan, C., Serpi, M., Ślusarczyk, M., Ferrari, V., Pertusati, F., Meneghesso, S., Derudas, M., Farleigh, L. E., Zanetta, P., & Bugert, J. J. (2016) · ChemistryOpen · doi:10.1002/open.201500216 · Cited by 24
Diagnosis of dengue in Sri Lanka: improvements to the existing state of the art in the island
Senaratne, T., & Noordeen, F. (2014) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/tru131 · Cited by 24
Immunopathogenesis of Dengue Virus-Induced Redundant Cell Death: Apoptosis and Pyroptosis
Suwanmanee, S., & Luplertlop, N. (2016) · Viral Immunology · doi:10.1089/vim.2016.0092 · Cited by 24
“Dengue viruses include four specific serotypes: DENV-1, DENV-2, DENV-3, and DENV-4, which are distributed in different regions (6,18,32,45,46,50).”
InfluentialThanigaivel, A., Vasantha‐Srinivasan, P., Edwin, E., Ponsankar, A., Selin‐Rani, S., Chellappandian, M., Kalaivani, K., Senthil‐Nathan, S., & Benelli, G. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-9102-6 · Cited by 24
Low density lipopolyprotein inhibits flavivirus acquisition in Aedes aegypti
Wagar, Z. L., Tree, M. O., Mpoy, M. C., & Conway, M. J. (2017) · Insect Molecular Biology · doi:10.1111/imb.12334 · Cited by 24
“DENV is a re-emerging human pathogen with global reach (Guzman et al., 2010).”
BackgroundBadreddine, S. A., Al-Dhaheri, F., AlDabbagh, A., Alamoudi, A. A., Al‐Ammari, M., Elatassi, N., Abbas, H., Magliah, R., Malibari, A., & Almoallim, H. M. (2017) · Saudi Medical Journal · doi:10.15537/smj.2017.10.20965 · Cited by 24
“3 (1-10) days after onset of fever for pediatric patients.”
BackgroundInfluentialEpitope Sequences in Dengue Virus NS1 Protein Identified by Monoclonal Antibodies
Rocha, L. B., Alves, R. P. D. S., Caetano, B., Pereira, L. R., Mitsunari, T., Amorim, J. H., Polatto, J. M., Botosso, V. F., Gallina, N. M. F., Palácios, R., et al. (2017) · Antibodies · doi:10.3390/antib6040014 · Cited by 24
“Dengue fever is an important mosquito-borne and the most prevalent and costly arbovirus affecting humans, caused by one of the four serotypes of dengue virus (DENV 1–4) [1].”
BackgroundC-Type Lectin-20 Interacts with ALP1 Receptor to Reduce Cry Toxicity in Aedes aegypti
Batool, K., Alam, I., Zhao, G., Wang, J., Xu, J., Yu, X., Huang, E., Guan, X., & Zhang, L. (2018) · Toxins · doi:10.3390/toxins10100390 · Cited by 24
Kinimi, E., Shayo, M. J., Patrick, B. N., Angwenyi, S., Kasanga, C. J., Weyer, J., van Vuren, P. J., Paweska, J. T., Mboera, L. E. G., & Misinzo, G. (2018) · Infection Ecology & Epidemiology · doi:10.1080/20008686.2018.1553460 · Cited by 24
Onyedibe, K. I. (2018) · Malawi Medical Journal · doi:10.4314/mmj.v30i4.11 · Cited by 24
An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2
Tang, C., Li, P., Liu, I.-J., Liao, M., Chiu, C., Chao, D., & Wu, H. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003903 · Cited by 24
“It is a positive-stranded RNA virus that encodes three structural proteins (the capsid (C), pre-membrane (prM), and envelope (E) proteins) and seven non-structural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b and NS5) [10,11].”
BackgroundGnankiné, O., & Dabiré, R. K. (2024) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2024.1329015 · Cited by 23
“Among the arboviroses, i.e., yellow fever virus (YFV), Zika virus, Chikungunya virus (CHYKV), and dengue virus, transmitted generally by Ae. aegypti , dengue virus is the most prevalent in subtropical and tropical areas and remains a major public health concern (2).”
Antiviral macrophage responses in flavivirus encephalitis.
Ashhurst, T. M., van Vreden, C., Munoz‐Erazo, L., Niewold, P., Watabe, K., Terry, R. L., Deffrasnes, C., Getts, D. R., & King, N. J. C. (2013) · PubMed Central · Cited by 33
Hoffmeister, B., Suttorp, N., & Zöller, T. (2014) · Infection · doi:10.1007/s15010-014-0688-z · Cited by 23
A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement
Londono-Renteria, B. L., Troupin, A., Cardenas, J. C., Hall, A., Perez, O., Cardenas, L. D., Hartstone‐Rose, A., Halstead, S. B., & Colpitts, T. M. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000833 · Cited by 26
Self-citationWolbachia strain wAlbB blocks replication of flaviviruses and alphaviruses in mosquito cell culture
Ekwudu, O., Devine, G. J., Aaskov, J., & Frentiu, F. D. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-3936-3 · Cited by 23
Serological Diagnosis of Dengue
Lima, M. R. Q., Nunes, P. C. G., & dos Santos, F. B. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1879-0_12 · Cited by 23
Drugs for dengue: a patent review (2010 – 2014)
Beesetti, H., Khanna, N., & Swaminathan, S. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.967212 · Cited by 26
“This, in the context of the recent availability of rapid diagnostic tests based on NS1 antigen detection [7], provides the rationale that underlies current efforts that seek to develop antiviral therapeutic agents against dengue [14].”
BackgroundChen, R., Wang, L., Cheng, J., & Yang, K. D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-340 · Cited by 23
“Occasional, DF progresses to dengue hemorrhagic fever (DHF), a potentially life threatening complication associated with vascular leakage, hemorrhage, thrombocytopenia and shock [3-5].”
BackgroundAcosta, E. G., Piccini, L. E., Talarico, L. B., Castilla, V., & Damonte, E. B. (2014) · Virus Research · doi:10.1016/j.virusres.2014.02.011 · Cited by 23
Prophylactic Platelets in Dengue: Survey Responses Highlight Lack of an Evidence Base
Whitehorn, J., Rodríguez, R., Guzmán, M. G., Martinez, E., Villamil‐Gómez, W. E., Nainggolan, L., Laksono, I. S., Mishra, A. K., Lum, L. C. S., Faiz, A., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001716 · Cited by 23
“5 billion people worldwide [1].”
Self-citationBacci, A., Marchi, S., Fiévet, N., Massougbodji, A., Perrin, R. X., Chippaux, J., Sambri, V., Landini, M. P., Varani, S., & Rossini, G. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0092 · Cited by 23
Innovative dengue vector control interventions in Latin America: what do they cost?
Alfonso-Sierra, E., Basso, C., Beltrán‐Ayala, E., Mitchell‐Foster, K., Quintero, J., Cortés, S., Manrique-Saide, P. C., Guillermo-May, G., Caprara, A., de Lima, E. C., et al. (2016) · Pathogens and Global Health · doi:10.1080/20477724.2016.1142057 · Cited by 26
Self-citationSocial and Environmental Determinants of Dengue Infection Risk in North Sumatera Province, Indonesia
Siregar, F. A., Abdu, M. R., Omar, J., Sarumpaet, S. M., Supriyadi, T., Makmur, T., & Huda, N. (2015) · Asian Journal of Epidemiology · doi:10.3923/aje.2015.23.35 · Cited by 23
Taylor-Robinson, A. W. (2016) · International Journal of Clinical & Medical Microbiology · doi:10.15344/2456-4028/2016/101 · Cited by 23
“101 showing around 65% sequence homology [7], while the newer virus, though resembling closest DENV-4, is thought to be phylogenetically distinct [15].”
BackgroundResultTalarico, L. B., Batalle, J. P., Byrne, A. B., Brahamian, J. M., Ferretti, A. J. P., García, A. G., Mauri, A., Simonetto, C., Hijano, D. R., Lawrence, A., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.033 · Cited by 23
“The global incidence of severe dengue disease is increasing (Guzman et al., 2010).”
BackgroundDengue fever: Pakistan’s worst nightmare
Shakoor, M. T., Ayub, S., & Ayub, Z. (2012) · WHO South-East Asia Journal of Public Health · doi:10.4103/2224-3151.207018 · Cited by 23
“WHO South-East Asia Journal of Public Health 2012;1(3):229-231 230 Dengue fever: Pakistan’s worst nightmare Muhammad T Shakoor et al.”
BackgroundFicus septica plant extracts for treating Dengue virus in vitro
Huang, N., Hung, W.-T., Tsai, W., Lai, F.-Y., Lin, Y.-S., Huang, M.-S., Chen, J., Lin, W.-Y., Weng, J.-R., & Chang, T.-H. (2017) · PeerJ · doi:10.7717/peerj.3448 · Cited by 23
“Dengue fever is an acute infectious disease caused by dengue virus (DENV), which is transmitted by mosquitoes to humans; about 50 million people are infected per year worldwide (Guzman et al., 2010).”
BackgroundInfluentialAnti-dengue serotype-2 activity effect of Sambucus nigra leaves-and flowers-derived compounds
Maldonado, I. C., Moreno‐Altamirano, M. M. B., & Serrano‐Gallardo, L. B. (2017) · Virology Research and Reviews · doi:10.15761/vrr.1000117 · Cited by 23
“DENV is a Flavivirus, its positive singlestranded RNA encodes for 10 proteins [2].”
BackgroundMachine learning for dengue outbreak prediction: An outlook
Iqbal, N., & Islam, M. T. (2017) · International Journal of Advanced Research in Computer Science · doi:10.26483/ijarcs.v8i1.2859 · Cited by 23
“NS family (1/2A/2B/3/4A/4B/5) Nonstructural protein 1 [25]”
Chien, Y., Huang, H.-M., Ho, T., Tseng, F., Ko, N., Ko, W., & Perng, G. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3946-y · Cited by 23
Cartography of odor chemicals in the dengue vector mosquito (Aedes aegypti L., Diptera/Culicidae)
Wang, F., Delannay, C., Goindin, D., Deng, L., Guan, S., Lu, X., Fouque, F., Vega-Rúa, A., & Picimbon, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-44851-7 · Cited by 23
Differences in the Transmission of Dengue Fever by Different Serotypes of Dengue Virus
Niu, C., Huang, Y., Wang, M., Huang, D., Li, J., Huang, S., Yang, F., Wan, C., & Zhang, R. (2019) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2019.2477 · Cited by 23
“Guzman et al.’s (2010) results indicated that, the infection order of different sero-types of DENV can affect the severity of clinical symptoms.”
Prioritizing Water Security in the Management of Vector‐Borne Diseases: Lessons From Oaxaca, Mexico
Akanda, A. S., Johnson, K., Ginsberg, H. S., & Couret, J. (2020) · GeoHealth · doi:10.1029/2019gh000201 · Cited by 28
“Uncontrolled and unplanned urbanization, population growth, poverty, and ineffective vector control services and abatement strategies are critical factors that can foster local mosquito populations (Gubler, 2010; Guzman et al., 2010; Kraemer et al., 2019).”
BackgroundAvila‐Bonilla, R. G., Yocupicio‐Monroy, M., Marchat, L. A., Pérez-Ishiwara, D. G., Cerecedo, D., del Ángel, R. M., & Salas-Benito, J. S. (2020) · Journal of General Virology · doi:10.1099/jgv.0.001441 · Cited by 23
Burden of communicable diseases and cost of illness: Asia pacific region
Shah, S., Abbas, G., Riaz, N., Rehman, A. U., Hanif, M., & Rasool, M. F. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1782196 · Cited by 23
Association of genotype III of dengue virus serotype 3 with disease outbreak in Eastern Sudan, 2019
Eldigail, M. H., Abubaker, H. A., Khalid, F. A., Abdallah, T. M., Musa, H. H., Ahmed, M. E., Adam, G. K., Elbashir, M. I., & Aradaib, I. E. (2020) · Virology Journal · doi:10.1186/s12985-020-01389-9 · Cited by 23
“In areas of endemicity of eastern Sudan, concurrent or previous infection with heterologous DENV serotype may result in complicated hemorrhagic manifestation leading to significant mortalities among the infected patients [6, 7, 32].”
BackgroundDengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past
Islam, R., Salahuddin, M., Ayubi, M. S., Hossain, T., Majumder, A., Taylor-Robinson, A. W., & Mahmud-Al-Rafat, A. (2015) · Virologica Sinica · doi:10.1007/s12250-015-3624-1 · Cited by 23
“Dengue virus comprises an enveloped, positive-strand genome of approximately 11 kb in length, which encodes three structural and seven non-structural proteins (Ma et al., 2004; Guzman et al., 2010; Rodenhuis-Zybert et al., 2010).”
BackgroundRole of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome
Tsai, J., Chokephaibulkit, K., Chen, P.-C., Liu, L., Hsiao, H., Lo, Y.-C., & Perng, G. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-88 · Cited by 23
Clarke, J. N., Davies, L. T., Calvert, J. K., Gliddon, B. L., Shujari, W. H. A., Aloia, A. L., Helbig, K. J., Beard, M. R., Pitson, S. M., & Carr, J. M. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000334 · Cited by 22
Repurposing of approved drug molecules for viral infectious diseases: a molecular modelling approach
Kumar, N., Sarma, H., & Sastry, G. N. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1905558 · Cited by 24
“The World Health Organization declares as a public health emergency when the emergence and re-emergence of these viruses (Burt et al., 2012; Gulland, 2016; Guzman, 2010; Howard & Fletcher, 2012; Lai et al., 2020; Staples et al., 2009).”
BackgroundLaydon, D. J., Dorigatti, I., Hinsley, W. R., Nedjati-Gilani, G. L., Coudeville, L., & Ferguson, N. M. (2021) · eLife · doi:10.7554/elife.65131 · Cited by 23
Lefebvre, B., Karki, R., Misslin, R., Nakhapakorn, K., Daudé, É., & Paul, R. E. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610123 · Cited by 25
“The disease is endemic in over 100 countries [2,3].”
BackgroundRapid molecular assays for the detection of the four dengue viruses in infected mosquitoes
Ahmed, M., Pollak, N. M., Hugo, L. E., van den Hurk, A. F., Hobson‐Peters, J., & Macdonald, J. (2022) · Gates Open Research · doi:10.12688/gatesopenres.13534.1 · Cited by 22
Li, H.-H., Su, M. P., Wu, S.-C., Tsou, H., Chang, M.-C., Cheng, Y., Tsai, K.-N., Wang, H., Chen, G., Tang, C.-K., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104723 · Cited by 22
Messenger, A. M., Barr, K. L., Weppelmann, T. A., Barnes, A. N., Anderson, B. D., Okech, B. A., & Focks, D. A. (2014) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2014.1665 · Cited by 22
“This information is critical considering the consequences of sequential DENV infections, which are associated with more severe symptoms such as DHF, DSS, and death (Guzman et al. 2010).”
Detection of dengue group viruses by fluorescence in situ hybridization
Raquin, V., Wannagat, M., Zouache, K., Legras‐Lachuer, C., Moro, C. V., & Mavingui, P. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-243 · Cited by 30
“The geographic area of DF transmission has expanded considerably during recent decades, and the number of cases reported has increased more than 30-fold since the 1960s [1].”
BackgroundGraph hierarchies for phylogeography
Cybis, G. B., Sinsheimer, J. S., Lemey, P., & Suchard, M. A. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0206 · Cited by 22
Bhatti, A. B., Ali, F., & Satti, S. A. (2015) · Cureus · doi:10.7759/cureus.396 · Cited by 22
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.